NWPF

News ArchivesRead News

New finding could help Parkinson's patients

Tuesday December 11, 2012

Swedish scientists may have discovered a way of stopping dyskinesia, or involuntary movements, in mid-to-late stage Parkinson's disease.

thelocal.se - In tests with laboratory animals, the Swedish scientists managed to stop the movements completely, having identified the area of the brain where the debilitating movements are activated as a side effect of the medication L-dopa.

Scientists told Sveriges Radio (SR) that the aim is now to develop new medication suitable for humans.

Such an achievement would essentially mean finding a cure for Parkinson's, or it would at least constitute a functioning treatment, according to Pär Halje, a neuroscience researcher at Lund University.

"We were very surprised, I have to admit," said Per Pettersson, a neurophysiology researcher at Lund University.

"We had not expected this at all, but since the phenomenon was so clear and was repeated in all lab animals in each test, we realized that we had discovered a new pathophysiological phenomenon."

The symptoms of Parkinson’s disease are caused by a breakdown of nerve cells that produce dopamine. This causes slow movement, tremors and stiffness, which can be controlled by medication, but the debilitating side effects kick in after around five years.

Up until now, scientists have believed that the involuntary movements are activated in a deep part of the brain, but the Lund University researchers have for the first time been able to demonstrate that it is the shallow parts of the brain that after several years of treatment become oversensitive to the Parkinson's disease medication.

With the help of advanced technology, they were able to track brain activity in rats with Parkinson's and could block the parts of the cerebral cortex that had become oversensitive to the medication.

In Sweden, around 20,000 people suffer from Parkinson's disease.

Recent News

May 20 - Book Review: Aging in the Key of Humor
May 19 - Press Release: The Michael J. Fox Foundation for Parkinson's Research Joins Multinational Critical Path for Parkinson's Consortium
May 19 - Congress reaches deal to overhaul chemical regulation
May 16 - Lifestyle: Why Parkinson's disease won't stop me rowing across the Pacific
May 16 - Many biomarkers for PD fail to inform on progression
May 10 - Parkinson's Cell Transplant Shows Good Reinnervation at 24 Years
May 7 - Growing art installation gathers stories of living with Parkinson's
May 5 - New technique can provide better cell transplants against Parkinson's disease
May 2 - What's Good For The Heart Is Good For The Brain
Apr 29 - Press Release: FDA approves first drug to treat hallucinations and delusions associated with Parkinson’s disease
Apr 28 - Dopamine-making neurons can be chemically controlled in animal model of Parkinson's
Apr 25 - Lifestyle: Dating with Disease
Apr 25 - Scientific breakthrough in fight against Parkinson's and Alzheimer's
Apr 20 - Breakthrough Parkinson's disease blood test
Apr 15 - Living with Parkinson's
Apr 12 - Tissue biomarker for dementia with Lewy bodies and Parkinson’s disease
Apr 11 - Yoga for Every Body: Experts say yoga can ease pain and improve mobility for people with neurologic conditions
Apr 9 - Commonly prescribed Parkinson's drugs up risk of compulsive gambling, shopping, binge eating, hypersexuality
Apr 7 - Pfizer and IBM Launch Innovative Research Project to Transform Parkinson's Disease Care
Apr 7 - Parkinson's Drug Highly Effective for Resistant Depression